Skin Care Information
More articles below:
Botox Injections May Relieve Tennis Elbow Pain
Skin Condition Vitiligo Tied to Immune System Dysfunction
Prevention of Acupuncture Infection Needs More Focus
Heat Therapy Helps Treat U.S. Soldiers' Infections
Scientists Find Stem Cells in Hair That Can Become Skin
Cell Transplant May Help Treat Vitiligo
Molecule May Trigger Psoriasis
FRIDAY, Jan. 18 (HealthDay News) -- A molecule may play a major role in the development of psoriasis, offering a new way to treat this chronic skin disease, a study finds.
A team at Wyeth Research, in Cambridge, Mass., found that antibodies that neutralized the IL-22 molecule in mice prevented the development of psoriasis-like lesions. The researchers also found injecting IL-22 into the skin of normal mice activated genes associated with the development of psoriasis-like skin lesions.
These findings, published in the Jan. 17 issue of the Journal of Clinical Investigation, suggest that targeting IL-22 may provide a new approach to treating people with psoriasis, the study authors said.
Psoriasis, which causes red, scaly, raised skin lesions, affects up to 3 percent of the world's population and more than 7.5 million Americans, according to the National Psoriasis Association.
More information
The U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases has more about psoriasis.
DON'T HAVE Rx COVERAGE?Click Here to print out your FREE OPTIMIZERx Card and instantly begin savings on your next prescriptions!
